Toxicity of breast cancer treatment

Women being treated for breast cancer are typically told to expect some side effects, but a new study reveals that far more women than realized experience severe or very severe effects —

even those who didn’t receive chemotherapy. Researchers at the University of Michigan and Stanford University found that nearly half of women (45 percent) treated for early-stage breast

cancer reported at least one severe or very severe effect, often leading to additional doctor’s appointments, trips to the emergency room and delays in treatment or reduced dosages. The

findings from the study, published in the journal _Cancer__,_ show that the rate of these severe side effects is higher than expected, said coauthor Allison Kurian, M.D., who is a health

researcher at Stanford University School of Medicine. “Often women suffer in silence, afraid to tell providers about how bad things really are, for fear that their treatments may be halted.

We need to change that.” Up to now, most information on the toxicity of breast-cancer-treatment side effects came from clinical trial data or health care claims, which “may be biased,”

researchers wrote. Few studies sought direct input from patients. So the researchers surveyed nearly 2,000 patients with early-stage invasive breast cancer, the most common type of breast

cancer in the U.S. This stage involves small tumors that have not spread to other parts of the body. Patients have surgery to remove part or all of the breast, sometimes followed by surgery

and/or radiation to kill any lingering cancer cells. In the survey, women were asked to rate the severity of seven common side effects of breast cancer treatment: pain; nausea or vomiting;

skin irritation; arm swelling; difficulty breathing; diarrhea; and constipation. Among the survey’s findings: * Ninety-three percent of women overall said they experienced at least one side

effect, with 45 percent rating it severe or very severe. * Pain, constipation and skin irritation were most frequently reported as the most toxic side effects. * Women who received chemo

were twice as likely as those who didn’t to report a severe side effect, and those who received both chemo and radiation were 30 percent more likely to experience a toxic side effect

compared to those who only had only one of those treatments. * Women who had a double mastectomy (removal of both breasts) were twice as likely as those who underwent a lumpectomy (removal

of part of a breast) to experience severe or very severe pain. * Severe side effects were 30 percent more likely for Latina women than white women. * Nearly 20 percent of those who didn’t

get chemo still reported severe or very severe pain. Obviously, those who received more therapy could suffer more effects, and the study didn’t look at whether physicians were following

guidelines on timing and dosages, which can affect the toxicity of treatment. But Kurian also noted that oncologists need to encourage patients to share information about the side effects

they’re experiencing and to help women manage these effects more effectively.